Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana
Open Access
- 16 July 2020
- Vol. 12 (7), 766
- https://doi.org/10.3390/v12070766
Abstract
Nasopharyngeal cancer (NPC) is associated with Epstein Barr virus (EBV) infection. However different viral strains have been implicated in NPC worldwide. This study aimed to detect and characterize EBV in patients diagnosed with NPC in Ghana. A total of 55 patients diagnosed with NPC by CT scan and endoscopy were age-matched with 53 controls without a known oncological disease. Venous blood was collected from the study participants and DNA extracted from the blood samples. Detection of EBV and genotyping were done by amplifying Epstein Barr nuclear antigen 1 (EBNA-1) and Epstein Barr nuclear antigen 2 (EBNA-2), respectively, using specific primers. Viral load in patients and controls was determined using real-time polymerase chain reaction. EBV positivity in controls (92%) was significantly greater than that of NPC patients (67%) (χ2 = 19.17, p < 0.0001), and viral infection was independent of gender (χ2 = 1.770, p = 0.1834). The predominant EBV genotypes in patients and controls were genotype 2 (52%) and genotype 1 (62%), respectively. Median EBV load was significantly higher in NPC patients than the control group (p < 0.01). In summary, prevalence of EBV genotype 2 infection was higher in NPC patients than the control group. Assessment of EBV load may be used as a biomarker for the diagnosis of NPC.Keywords
Funding Information
- World Bank Group (ACE02-WACCBIP: Awandare)
This publication has 34 references indexed in Scilit:
- Nasopharyngeal CarcinomaHead and Neck Pathology, 2012
- Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dyeVirology Journal, 2010
- Detecção de Epstein-Barr vírus no carcinoma da nasofaringe: implicações numa área de baixo riscoBrazilian Journal of Otorhinolaryngology, 2010
- Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinomaJournal of Translational Medicine, 2008
- Distribution of Epstein–Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinomaJournal of Medical Virology, 2006
- Diagnostic Value of Measuring Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral mRNA in Relation to Anti-EBV Immunoglobulin A (IgA) and IgG Antibody Levels in Blood of Nasopharyngeal Carcinoma Patients from IndonesiaJournal of Clinical Microbiology, 2005
- Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal CarcinomaThe New England Journal of Medicine, 2004
- Persistence of the Epstein–Barr Virus and the Origins of Associated LymphomasThe New England Journal of Medicine, 2004
- Frequent presence of subtype A virus in Epstein–Barr virus-associated malignanciesPathology, 2002
- Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical SpecimenJournal of Clinical Microbiology, 2001